Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac ion channels are membrane-embedded proteins critical for the generation and propagation of electrical impulses in the heart. These include multiple families—voltage-gated sodium, calcium, and potassium channels—and are responsible for the phases of the cardiac action potential. Modulation of these channels, whether by drugs or endogenous factors, offers a vital therapeutic approach in treating cardiac arrhythmias, hypertension, and other heart diseases, but requires careful balance due to the risk of adverse events such as proarrhythmia. Instead of representing a single molecular target, "cardiac ion channel modulation" encompasses modulation of several distinct ion channel types, each with specific molecular identity and therapeutic relevance.
Channel blockade (inhibition of ion flux); Channel activation (facilitation of ion flux); Channel modulation (change gating properties, e.g., prolongation/reduction of action potential duration); Altered channel expression or trafficking; Allosteric modulation (affecting associated proteins)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac ion channel modulation.